Your shopping cart is currently empty

Synonyms: Rupintrivirvr, AG-7088, AG7088


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $118 | In Stock | In Stock | |
| 5 mg | $263 | In Stock | In Stock | |
| 10 mg | $419 | In Stock | In Stock | |
| 25 mg | $737 | In Stock | In Stock | |
| 50 mg | $977 | - | In Stock | |
| 100 mg | $1,290 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $347 | In Stock | In Stock |
| Description | Rupintrivir (AG7088) is an antiviral agent and an irreversible inhibitor targeting human rhinovirus 3C protease (EC50 = 0.023 μM), featuring high selectivity and immunomodulatory activity, capable of effectively inhibiting multiple HRV serotypes as well as EV71 and EV-D68 replication, commonly used for research on viral infection mechanisms. |
| Targets & IC50 | RD cells:0.009 μM (EC50), H1-HeLa cells:14 nM (EC50), rhinovirus (HRV) 3C cysteine protease mimetic peptide:0.023 μM (EC50), Vero cells:0.419 μM (EC50), HeLa cells:0.27 μM (EC50) |
| In vitro | Methods: RD cells were incubated with gradient concentrations of Rupintrivir for 3–4 days. Results: Rupintrivir showed potent inhibition against EV-D68, RV-87, and EV-71, with EC₅₀ of 0.0022–0.0053 μM and EC₉₀ of 0.004 μM against EV-D68, demonstrating the strongest activity among ten tested compounds. [1] Methods: A fluorescence resonance energy transfer (FRET) assay was used. Gradient concentrations of Rupintrivir were co-incubated with purified DHAV 3C protease and fluorescent substrate for 2 hours. Results: It showed inhibitory activity against duck hepatitis A virus 3C protease. [2] |
| In vivo | Methods: Precision-cut lung slices were prepared from HDM-sensitized Balb/c mice, infected ex vivo with RV1b (10⁵ TCID₅₀/mL), and treated with 100 nM Rupintrivir for 48 hours. Results: Rupintrivir significantly inhibited RV-induced excessive secretion of IL-4 and IL-6 in the HDM-sensitized group without affecting interferon responses. [3] |
| Synonyms | Rupintrivirvr, AG-7088, AG7088 |
| Molecular Weight | 598.66 |
| Formula | C31H39FN4O7 |
| Cas No. | 223537-30-2 |
| Smiles | CCOC(=O)\C=C\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1 |
| Relative Density. | 1.31g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 252.5 mg/mL (421.78 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 2 mg/mL (3.34 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.